Selecta Biosciences reportedly gets $15M in Series C financing

Selecta Biosciences says it has obtained $15 million in a round of venture financing led by OrbiMed Advisors. The Watertown, Mass.-based company plans to use the proceeds to further develop its nanotech-based, synthetic vaccines.

View Full Article in:

Boston Globe (tiered subscription model), The · Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX